Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis
International Immunopharmacology · 2023-07 · 120 · 110356
DOI: 10.1016/j.intimp.2023.110356 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-07. Verfasst von Maoyao Ling und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China; Guangxi Engineering Research Center for Tissue & Organ Inju…. Hauptthemen laut MEDLINE: Ferroptosis, Ventilator-Induced Lung Injury. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province.
Abstract (Originalsprache)
Ventilator-induced lung injury (VILI) has become an increasingly common complication in the clinic concerning mechanical ventilation. Previous research showed that VILI is the result of a response to cascade inflammation; however, the inflammatory mechanism involved remains unclear. As a newly recognized form of cell death, ferroptosis can release damage-related molecules (DAMPs) to trigger and amplify the inflammatory response and is involved in several inflammatory diseases. The present study aimed to investigate a previously unrecognized role of ferroptosis in VILI. A mouse model of VILI and a model of cyclic stretching (CS)-induced lung epithelial cell injury were established. Mice and cells were pretreated with ferrostain-1, an inhibitor of ferroptosis. Lung tissue and cells were then harvested to determine lung injury, inflammatory responses, indicators and protein expression associated with ferroptosis. Compared to the control group, mice subjected to high tidal volumes (HTV) for 4 h showed more severe pulmonary edema and inflammation and the activation of ferroptosis. Ferrostain-1 significantly ameliorated histological injury and inflammation in the VILI mouse and alleviated CS-induced lung epithelial cell injury. Mechanistically, ferrostain-1 markedly limited the activation of ferroptosis and recovered functionality of the SLC7A11/GPX4 axis both in vitro and in vivo, thus demonstrating its potential as a novel therapeutic target for VILI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China; Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine, Nanning, China; Guangxi Health Commission Key…
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Ling, M., Ye, L., Zeng, Q., Li, Z., He, S., Lin, J., Mo, J., & Pan, L. (2023). Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis. International Immunopharmacology, 120, 110356. https://doi.org/10.1016/j.intimp.2023.110356
Vancouver
Ling M, Ye L, Zeng Q, Li Z, He S, Lin J, et al. Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis. International Immunopharmacology. 2023;120:110356. doi:10.1016/j.intimp.2023.110356
BibTeX
@article{Ling2023,
author = {Ling, Maoyao and Ye, Liu and Zeng, Qi and Li, Zhao and He, Sheng and Lin, Jinyuan and Mo, Jianlan and Pan, Linghui},
title = {Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis},
journal = {International Immunopharmacology},
year = {2023},
volume = {120},
pages = {110356},
doi = {10.1016/j.intimp.2023.110356}
}
EUVIMED